- Home
- MGX vs APT Comparison
MGX vs APT Comparison
Compare MGX & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGX
- APT
- Stock Information
- Founded
- MGX 2018
- APT 1983
- Country
- MGX United States
- APT Canada
- Employees
- MGX N/A
- APT N/A
- Industry
- MGX
- APT
- Sector
- MGX
- APT
- Exchange
- MGX NYSE
- APT Nasdaq
- Market Cap
- MGX 62.1M
- APT 50.5M
- IPO Year
- MGX 2024
- APT 1995
- Fundamental
- Price
- MGX $1.52
- APT $4.85
- Analyst Decision
- MGX Strong Buy
- APT
- Analyst Count
- MGX 4
- APT 0
- Target Price
- MGX $13.00
- APT N/A
- AVG Volume (30 Days)
- MGX 665.7K
- APT 34.2K
- Earning Date
- MGX 08-13-2025
- APT 08-06-2025
- Dividend Yield
- MGX N/A
- APT N/A
- EPS Growth
- MGX N/A
- APT 2.28
- EPS
- MGX N/A
- APT 0.36
- Revenue
- MGX $45,263,000.00
- APT $58,180,000.00
- Revenue This Year
- MGX N/A
- APT N/A
- Revenue Next Year
- MGX $11.75
- APT N/A
- P/E Ratio
- MGX N/A
- APT $13.01
- Revenue Growth
- MGX N/A
- APT N/A
- 52 Week Low
- MGX $1.23
- APT $4.06
- 52 Week High
- MGX $5.50
- APT $6.44
- Technical
- Relative Strength Index (RSI)
- MGX 47.41
- APT 51.78
- Support Level
- MGX $1.46
- APT $4.68
- Resistance Level
- MGX $1.66
- APT $4.87
- Average True Range (ATR)
- MGX 0.13
- APT 0.15
- MACD
- MGX 0.00
- APT 0.00
- Stochastic Oscillator
- MGX 46.30
- APT 50.00
About MGX METAGENOMI INC
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is in the business of protecting people, products and environments. It is developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. It also manufacture a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment and synthetic roof underlayment accessories.